Trade LifeMD, Inc. - LFMD CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
Trading сonditions
| Spread | 0.09 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Key Stats
| Prev. Close* | 9.95 |
| Open* | 9.81 |
| 1-Year Change* | 498.17% |
| Day's Range* | 9.67 - 10.01 |
| 52 wk Range | 1.14-9.11 |
| Average Volume (10 days) | 1.98M |
| Average Volume (3 months) | 18.42M |
| Market Cap | 227.87M |
| P/E Ratio | -100.00K |
| Shares Outstanding | 37.98M |
| Revenue | 135.81M |
| EPS | -0.99 |
| Dividend (Yield %) | N/A |
| Beta | 1.35 |
| Next Earnings Date | Mar 20, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 22, 2024 | 9.95 | 0.34 | 3.54% | 9.61 | 10.02 | 9.61 |
| Apr 19, 2024 | 9.67 | -0.30 | -3.01% | 9.97 | 10.20 | 9.51 |
| Apr 18, 2024 | 10.16 | 0.35 | 3.57% | 9.81 | 10.46 | 9.59 |
| Apr 17, 2024 | 9.82 | -0.09 | -0.91% | 9.91 | 10.06 | 9.72 |
| Apr 16, 2024 | 9.87 | 0.35 | 3.68% | 9.52 | 9.95 | 9.41 |
| Apr 15, 2024 | 9.57 | -0.08 | -0.83% | 9.65 | 9.98 | 9.42 |
| Apr 12, 2024 | 9.61 | -0.38 | -3.80% | 9.99 | 10.16 | 9.19 |
| Apr 11, 2024 | 10.19 | 0.41 | 4.19% | 9.78 | 10.24 | 9.56 |
| Apr 10, 2024 | 9.81 | 0.04 | 0.41% | 9.77 | 10.17 | 9.64 |
| Apr 9, 2024 | 10.22 | 0.25 | 2.51% | 9.97 | 10.24 | 9.87 |
| Apr 8, 2024 | 9.95 | 0.40 | 4.19% | 9.55 | 10.12 | 9.50 |
| Apr 5, 2024 | 9.52 | -0.01 | -0.10% | 9.53 | 9.91 | 9.33 |
| Apr 4, 2024 | 9.62 | -0.50 | -4.94% | 10.12 | 10.76 | 9.60 |
| Apr 3, 2024 | 10.10 | 0.37 | 3.80% | 9.73 | 10.19 | 9.72 |
| Apr 2, 2024 | 9.87 | -0.10 | -1.00% | 9.97 | 10.09 | 9.70 |
| Apr 1, 2024 | 10.17 | -0.05 | -0.49% | 10.22 | 10.56 | 9.94 |
| Mar 28, 2024 | 10.25 | 0.10 | 0.99% | 10.15 | 10.47 | 10.09 |
| Mar 27, 2024 | 10.12 | -0.91 | -8.25% | 11.03 | 11.03 | 10.09 |
| Mar 26, 2024 | 11.01 | 0.52 | 4.96% | 10.49 | 11.12 | 10.47 |
| Mar 25, 2024 | 10.55 | -0.60 | -5.38% | 11.15 | 11.25 | 10.52 |
LifeMD, Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| Friday, May 10, 2024 | ||
| Time (UTC) 12:30 | Country US
| Event Q1 2024 LifeMD Inc Earnings Release Q1 2024 LifeMD Inc Earnings ReleaseForecast -Previous - |
| Friday, June 14, 2024 | ||
| Time (UTC) 16:00 | Country US
| Event LifeMD Inc Annual Shareholders Meeting LifeMD Inc Annual Shareholders MeetingForecast -Previous - |
| Wednesday, August 7, 2024 | ||
| Time (UTC) 10:59 | Country US
| Event Q2 2024 LifeMD Inc Earnings Release Q2 2024 LifeMD Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total revenue | 119.034 | 92.8758 | 37.2939 | 12.4686 | 8.32413 |
| Revenue | 119.034 | 92.8758 | 37.2939 | 12.4686 | 8.32413 |
| Cost of Revenue, Total | 18.668 | 17.9954 | 8.86119 | 3.2706 | 1.96906 |
| Gross Profit | 100.365 | 74.8804 | 28.4327 | 9.19798 | 6.35507 |
| Total Operating Expense | 162.418 | 151.172 | 96.0282 | 15.3582 | 10.3803 |
| Selling/General/Admin. Expenses, Total | 130.364 | 124.951 | 84.7288 | 11.1404 | 8.41121 |
| Research & Development | 2.9702 | 0.77877 | 0.44675 | 0.22288 | |
| Operating Income | -43.3844 | -58.2966 | -58.7343 | -2.88961 | -2.05614 |
| Interest Income (Expense), Net Non-Operating | -1.27595 | -3.01972 | -1.66754 | -0.76115 | -0.35439 |
| Net Income Before Taxes | -44.6603 | -61.3164 | -60.4019 | -3.65076 | -2.41053 |
| Net Income After Taxes | -45.021 | -61.3241 | -60.5243 | -3.52826 | -2.28583 |
| Minority Interest | -0.51463 | 0.42635 | 1.87741 | 0.39106 | 0.11926 |
| Net Income Before Extra. Items | -45.5357 | -60.8977 | -58.6469 | -3.1372 | -2.16657 |
| Net Income | -45.5357 | -60.8977 | -58.6469 | -3.1372 | -1.24083 |
| Income Available to Common Excl. Extra. Items | -48.6419 | -61.7692 | -63.363 | -3.1372 | -2.16657 |
| Income Available to Common Incl. Extra. Items | -48.6419 | -61.7692 | -63.363 | -3.1372 | -1.24083 |
| Diluted Net Income | -48.6419 | -61.7692 | -63.363 | -3.1372 | -1.24083 |
| Diluted Weighted Average Shares | 30.9765 | 27.008 | 14.2752 | 9.89775 | 8.83748 |
| Diluted EPS Excluding Extraordinary Items | -1.57029 | -2.28707 | -4.43869 | -0.31696 | -0.24516 |
| Diluted Normalized EPS | -1.38565 | -2.19091 | -4.39703 | -0.31696 | -0.24516 |
| Unusual Expense (Income) | 8.7992 | 3.99556 | 0.91486 | 0 | |
| Total Extraordinary Items | 0 | 0.92574 | |||
| Other Operating Expenses, Total | 1.6168 | 3.4522 | 1.07666 | 0.72427 | |
| Total Adjustments to Net Income | -3.10625 | -0.87148 | -4.71602 |
| Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
|---|---|---|---|---|---|
| Total revenue | 35.9469 | 33.1263 | 28.1197 | 31.4125 | 30.4585 |
| Revenue | 35.9469 | 33.1263 | 28.1197 | 31.4125 | 30.4585 |
| Cost of Revenue, Total | 4.54843 | 4.21497 | 4.0677 | 4.71684 | 4.63531 |
| Gross Profit | 31.3985 | 28.9114 | 24.052 | 26.6956 | 25.8232 |
| Total Operating Expense | 40.8425 | 36.3043 | 36.0037 | 38.2302 | 46.0342 |
| Selling/General/Admin. Expenses, Total | 33.8055 | 29.0988 | 27.977 | 31.166 | 36.2763 |
| Research & Development | 1.38069 | 1.1836 | 1.01916 | 0.82164 | 0.70107 |
| Unusual Expense (Income) | 0 | 0.3252 | 6.1276 | 0 | 2.6716 |
| Other Operating Expenses, Total | 1.10779 | 1.48177 | -3.18783 | 1.52565 | 1.74997 |
| Operating Income | -4.89555 | -3.178 | -7.88394 | -6.8177 | -15.5757 |
| Interest Income (Expense), Net Non-Operating | -0.99567 | -0.26447 | -0.84354 | -0.13224 | -0.13224 |
| Net Income Before Taxes | -5.89122 | -3.44247 | -11.2145 | -7.19794 | -12.973 |
| Net Income After Taxes | -5.89122 | -3.44247 | -11.5752 | -7.19794 | -12.973 |
| Minority Interest | -0.84178 | -0.56598 | -0.36017 | -0.08374 | -0.046 |
| Net Income Before Extra. Items | -6.733 | -4.00846 | -11.9354 | -7.28167 | -13.019 |
| Net Income | -6.733 | -4.00846 | -11.9354 | -7.28167 | -13.019 |
| Total Adjustments to Net Income | -0.77656 | -0.77656 | -0.77656 | -0.77656 | -0.77656 |
| Income Available to Common Excl. Extra. Items | -7.50956 | -4.78502 | -12.7119 | -8.05824 | -13.7955 |
| Income Available to Common Incl. Extra. Items | -7.50956 | -4.78502 | -12.7119 | -8.05824 | -13.7955 |
| Diluted Net Income | -7.50956 | -4.78502 | -12.7119 | -8.05824 | -13.7955 |
| Diluted Weighted Average Shares | 32.56 | 31.6808 | 31.4142 | 30.9356 | 30.8045 |
| Diluted EPS Excluding Extraordinary Items | -0.23064 | -0.15104 | -0.40465 | -0.26048 | -0.44784 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Diluted Normalized EPS | -0.23064 | -0.14077 | -0.27787 | -0.26048 | -0.36111 |
| Other, Net | 0 | -2.487 | -0.248 | 2.735 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Current Assets | 11.3114 | 44.9214 | 12.4127 | 2.7471 | 1.60507 |
| Cash and Short Term Investments | 3.95896 | 41.328 | 9.17908 | 1.10662 | 0.18009 |
| Cash | 3.95896 | 41.328 | 9.17908 | 1.10662 | 0.18009 |
| Total Receivables, Net | 2.83475 | 0.98006 | 0.99776 | 0.09745 | 0.09905 |
| Accounts Receivable - Trade, Net | 2.83475 | 0.98006 | 0.99776 | 0.09745 | 0.09905 |
| Total Inventory | 3.70336 | 1.6166 | 1.26426 | 0.95006 | 1.02262 |
| Total Assets | 25.6658 | 49.9232 | 13.403 | 3.44618 | 2.61614 |
| Total Current Liabilities | 31.3741 | 22.8256 | 13.9324 | 3.97544 | 1.1924 |
| Payable/Accrued | 12.1434 | 3.05116 | 0.869 | ||
| Notes Payable/Short Term Debt | 2.79725 | 0.0634 | 0.77913 | 0.81473 | 0.24742 |
| Other Current Liabilities, Total | 8.21635 | 4.45619 | 0.91688 | 0.10955 | 0.07598 |
| Total Liabilities | 32.4958 | 23.0724 | 12.0491 | 4.43436 | 1.71844 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -0.47555 | -1.03175 | -2.17569 | -0.14106 | -0.07796 |
| Total Equity | -6.82996 | 26.8509 | 1.35392 | -0.98819 | 0.8977 |
| Common Stock | 0.31553 | 0.30705 | 0.23434 | 0.53404 | 0.45782 |
| Additional Paid-In Capital | 179.015 | 164.518 | 77.7794 | 15.2364 | 12.7443 |
| Retained Earnings (Accumulated Deficit) | -190.563 | -141.921 | -80.1519 | -16.5949 | -12.1407 |
| Treasury Stock - Common | -0.1637 | -0.1637 | -0.1637 | -0.1637 | -0.1637 |
| Total Liabilities & Shareholders’ Equity | 25.6658 | 49.9232 | 13.403 | 3.44618 | 2.61614 |
| Total Common Shares Outstanding | 31.4497 | 30.6014 | 23.3306 | 10.5777 | 9.05342 |
| Other Current Assets, Total | 0.81429 | 0.99675 | 0.97164 | 0.59297 | 0.30331 |
| Intangibles, Net | 12.6721 | 3.01555 | 0.71582 | 0.67545 | 1.01107 |
| Deferred Income Tax | 0.07 | 0.004 | |||
| Other Liabilities, Total | 1.59721 | 1.27854 | 0.29232 | 0.52998 | 0.6 |
| Property/Plant/Equipment, Total - Net | 1.68245 | 1.98625 | 0.27444 | 0.02363 | |
| Accrued Expenses | 10.2538 | 9.24679 | 0.093 | ||
| Redeemable Preferred Stock | 43.5435 | 39.9805 | 3.6575 | ||
| Preferred Stock - Non Redeemable, Net | -38.9775 | -35.8695 | -0.00168 | ||
| Accounts Payable | 10.1068 | 9.05921 | |||
| Total Preferred Shares Outstanding | 1.4 | 1.4 |
| Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|
| Total Current Assets | 24.8863 | 20.1809 | 19.1648 | 11.3114 | 12.9737 |
| Cash and Short Term Investments | 15.2883 | 11.9067 | 11.5248 | 3.95896 | 5.83682 |
| Cash | 15.2883 | 11.9067 | 11.5248 | 3.95896 | 5.83682 |
| Total Receivables, Net | 4.41858 | 3.66854 | 2.937 | 2.83475 | 2.53812 |
| Accounts Receivable - Trade, Net | 4.41858 | 3.66854 | 2.937 | 2.83475 | 2.53812 |
| Total Inventory | 3.79065 | 3.6983 | 3.38258 | 3.70336 | 3.67613 |
| Other Current Assets, Total | 1.38873 | 0.90731 | 1.32034 | 0.81429 | 0.92263 |
| Total Assets | 40.691 | 35.4464 | 33.8698 | 25.6658 | 33.3616 |
| Property/Plant/Equipment, Total - Net | 1.22374 | 1.37292 | 1.57724 | 1.68245 | 1.82281 |
| Intangibles, Net | 14.581 | 13.8926 | 13.1278 | 12.6721 | 12.9104 |
| Total Current Liabilities | 32.5219 | 31.5178 | 27.0186 | 31.3741 | 24.9353 |
| Payable/Accrued | |||||
| Notes Payable/Short Term Debt | 0.42622 | 0.73553 | 1.82249 | 2.79725 | 0 |
| Other Current Liabilities, Total | 9.02061 | 9.21038 | 8.68855 | 8.21635 | 4.76975 |
| Total Liabilities | 53.3622 | 46.435 | 41.1993 | 32.4958 | 29.4789 |
| Total Long Term Debt | 18.8273 | 13.5385 | 13.4231 | 0 | 0 |
| Minority Interest | 1.58691 | 0.78362 | -0.0315 | -0.47555 | -0.79972 |
| Other Liabilities, Total | 0.42607 | 0.59509 | 0.78911 | 1.59721 | 5.34333 |
| Total Equity | -12.6712 | -10.9886 | -7.32951 | -6.82996 | 3.88266 |
| Redeemable Preferred Stock | 41.216 | 45.549 | 44.4255 | 43.5435 | 42.63 |
| Common Stock | 0.34759 | 0.32565 | 0.3204 | 0.31553 | 0.31458 |
| Additional Paid-In Capital | 196.901 | 186.674 | 183.184 | 179.015 | 177.132 |
| Retained Earnings (Accumulated Deficit) | -209.757 | -202.858 | -195.348 | -190.563 | -177.851 |
| Treasury Stock - Common | -0.1637 | -0.1637 | -0.1637 | -0.1637 | -0.1637 |
| Total Liabilities & Shareholders’ Equity | 40.691 | 35.4464 | 33.8698 | 25.6658 | 33.3616 |
| Total Common Shares Outstanding | 34.6562 | 32.4618 | 31.937 | 31.4497 | 31.3547 |
| Long Term Debt | 18.8273 | 13.5385 | 13.4231 | ||
| Accounts Payable | 9.63739 | 9.59338 | 6.90303 | 10.1068 | 10.7975 |
| Accrued Expenses | 13.4377 | 11.9785 | 9.60454 | 10.2538 | 9.36799 |
| Goodwill, Net | 5.65467 | ||||
| Total Preferred Shares Outstanding | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 |
| Preferred Stock - Non Redeemable, Net | -41.2159 | -40.5159 | -39.7473 | -38.9775 | -38.1787 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -45.021 | -61.3241 | -60.5243 | -3.52826 | -1.36009 |
| Cash From Operating Activities | -22.9352 | -33.0855 | -12.1316 | 0.25141 | -0.90552 |
| Cash From Operating Activities | 0.16189 | 0.01356 | |||
| Deferred Taxes | 0.354 | ||||
| Non-Cash Items | 18.6222 | 18.2376 | 39.1978 | 1.37782 | 0.51477 |
| Cash Interest Paid | 0.189 | 0.43505 | 1.66517 | 0.08066 | 0.00438 |
| Changes in Working Capital | -0.66055 | 9.13218 | 8.79717 | 2.06623 | -0.25597 |
| Cash From Financing Activities | -0.5282 | 68.6367 | 21.0022 | 0.77512 | 0.80279 |
| Financing Cash Flow Items | -0.2881 | -0.444 | -0.17222 | -0.37316 | 0.15627 |
| Issuance (Retirement) of Stock, Net | 0.1289 | 70.483 | 21.0812 | 0.35 | 0.00408 |
| Issuance (Retirement) of Debt, Net | 2.73725 | -0.53082 | 0.09319 | 0.79828 | 0.64244 |
| Net Change in Cash | -37.3691 | 32.149 | 8.07245 | 0.92653 | 0.03871 |
| Amortization | 3.60835 | 0.8552 | 0.39777 | 0.33561 | 0.19578 |
| Cash From Investing Activities | -13.9057 | -3.40229 | -0.79814 | -0.1 | 0.14145 |
| Capital Expenditures | -8.89284 | -3.38006 | -0.39814 | 0 | -0.1 |
| Other Investing Cash Flow Items, Total | -5.0129 | -0.02223 | -0.4 | -0.1 | 0.24145 |
| Total Cash Dividends Paid | -3.10625 | -0.87148 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -3.44247 | -45.021 | -33.4459 | -26.2479 | -13.275 |
| Cash From Operating Activities | -2.61394 | -22.9352 | -20.9661 | -18.1901 | -8.09114 |
| Amortization | 1.32221 | 3.60835 | 2.41368 | 1.31731 | 0.49821 |
| Non-Cash Items | 2.69767 | 18.6222 | 13.4865 | 8.87612 | 4.59131 |
| Cash Interest Paid | 0.273 | 0.189 | 0 | 0 | 0 |
| Changes in Working Capital | -3.23899 | -0.66055 | -3.53749 | -2.20888 | 0.06182 |
| Cash From Investing Activities | -1.81164 | -13.9057 | -12.1347 | -9.89315 | -7.37819 |
| Capital Expenditures | -1.81164 | -8.89284 | -7.12182 | -4.88026 | -2.36529 |
| Other Investing Cash Flow Items, Total | 0 | -5.0129 | -5.0129 | -5.0129 | -5.0129 |
| Cash From Financing Activities | 11.9915 | -0.5282 | -2.39039 | -1.52748 | -0.77406 |
| Financing Cash Flow Items | -0.40501 | -0.2881 | -0.1896 | -0.10325 | -0.036 |
| Issuance (Retirement) of Stock, Net | 0 | 0.1289 | 0.1289 | 0.1289 | 0.0385 |
| Issuance (Retirement) of Debt, Net | 13.173 | 2.73725 | 0 | 0 | |
| Net Change in Cash | 7.56589 | -37.3691 | -35.4912 | -29.6107 | -16.2434 |
| Cash From Operating Activities | 0.04765 | 0.16189 | 0.11701 | 0.07325 | 0.03248 |
| Total Cash Dividends Paid | -0.77656 | -3.10625 | -2.32969 | -1.55313 | -0.77656 |
| Deferred Taxes | 0.354 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
Leverage
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
LifeMD, Inc. Company profile
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men''s sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a medical device for male and female hair loss; RexMD, a men''s telehealth brand that offers virtual medical treatment from licensed providers for a variety of men''s health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that would offer virtual medical treatment from dermatologists and other providers; and iNR Wellness MD, a supplement for immune and digestive support. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is based in New York, New York.| Industry: | Medical Software & Technology Services |
236 Fifth Avenue
Suite 400
NEW YORK
NEW YORK 10001
US
Income Statement
- Annual
- Quarterly
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com